Skip to main content
. 2025 Feb 5;13:1475357. doi: 10.3389/fpubh.2025.1475357

Table 5.

Antimicrobial susceptibility patterns of potential neonatal pathogen in public health facilities of Dessie town, Northeast Ethiopia, 2023.

Antibiotics Isolates, number (%)
GBS (n = 17) S. aureus (n = 24) E. coli (n = 153) Klebsiella spp. (n = 33) Acinetobacter spp. (n = 17)
S R S R S R S R S R
Ampicillin 15 (88.2) 2 (11.8) – – 10 (5.5) 143 (94.5) – – – –
Clindamycin 11 (64.7) 6 (35.3) 18 (75) 6 (25) – – – – – –
Erythromycin 8 (47.1) 9 (52.9) 11 (45.8) 13 (54.2) – – – – – –
Tetracycline 3 (17.6) 14 (82.4) 13 (54.2) 11 (45.8) – – – – – –
Cefoxitin – – 19 (79.2) 5 (20.8) – – – – – –
Penicillin 13 (76.5) 4 (23.5) 21 (87.5) 3 (12.5) – – – – – –
Chloramphenicol 12 (70.6) 5 (29.4) 22 (91.7) 2 (8.3) – – – – – –
Ciprofloxacin – – 13 (54.2) 11 (45.8) 75 (49.0) 78 (51.0) 14 (42.4) 19 (57.6) 10 (58.8) 7 (41.2)
Trimethoprim-Sulfamethoxazole – – 12 (50) 12 (50) 119 (77.7) 34 (22.3) 26 (78.8) 7 (21.2) 12 (70.6) 5 (29.4)
Ceftriaxone 14 (82.4) 3 (17.6) – – 85 (55.6) 68 (44.4) 18 (54.5) 15 (44.5) 4 (23.5) 13 (76.5)
Gentamicin – – 18 (75) 6 (25) 103 (67.3) 50 (32.7) 20 (60.7) 13 (30.3) 12 (70.6) 5 (29.4)
Amoxicillin -clavulanate – – – – 139 (90.9) 14 (9.1) 29 (87.9) 4 (12.1) – –
Amikacin – – – – 153 (100) 0 (0) 33 (100) 0 (0) 11 (64.7) 6 (36.3)
Imipenem – – – – 106 (69.3) 47 (30.7) 26 (78.8) 7 (21.2) 12 (70.6) 5 (29.4)
Meropenem – – – – 111 (72.5) 42 (27.5) 13 (39.3) 20 (60.7) 11 (64.7) 6 (35.3)
Ceftazidime – – – – 134 (87.6) 19 (12.4) 26 (78.8) 7 (21.2) 11 (64.7) 6 (35.3)
Aztreonam – – – – 139 (90.8) 14 (9.2) 32 (97) 1 (3.0) – –
Cefazolin – – – – 64 (41.8) 89 (58.2) 5 (15.1) 28 (84.9) – –

R, Resistant; S, Sensitive.